Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer

被引:104
作者
Junker, N
Johansen, JS
Andersen, CB
Kristjansen, PEG
机构
[1] Univ Copenhagen, Dept Mol Pathol, Expt Oncol Lab, DK-2100 Copenhagen, Denmark
[2] Univ Copenhagen, Herlev Hosp, Dept Rheumatol, DK-2100 Copenhagen, Denmark
[3] Univ Copenhagen, HS Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark
关键词
SCLC; TAM; CHI3L1; invasion; HC GP-39;
D O I
10.1016/j.lungcan.2004.11.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
YKL-40 is a 40 kDa protein with possible involvement in tissue remodeling, cell proliferation and angiogenesis. Elevated serum YKL-40 Levels in patients with metastatic cancers (including small cell lung cancer (SCLC)) are associated with poor prognosis. The aim of this study was to identify the cellular source of YKL-40 in SCLC patient biopsies and in a panel of 20 human SCLC lines cultured in vitro and in vivo in nude mice. In general, the SCLC cell lines had no or very limited (human) YKL-40 expression, whereas, by RT-PCR a pronounced murine (i.e., stromal) YKL-40 expression was present in all tumors. YKL-40 mRNA transcripts were detected by in situ hybridization in 9 of 10 biopsies from SCLC patients, and in each case the signal was localized in the peritumoral stroma in cells of typical macrophage morphology (confirmed by a CD68 macrophage specific stain). No YKL-40 mRNA expression was found in the cancer cells, in macrophages infiltrating the solid tumor areas, or in nonmalignant tissue. In conclusion, the predominant source of elevated serum YKL-40 in SCLC is peritumoral macrophages. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:223 / 231
页数:9
相关论文
共 55 条
[1]  
Baeten D, 2000, ARTHRITIS RHEUM, V43, P1233, DOI 10.1002/1529-0131(200006)43:6<1233::AID-ANR6>3.0.CO
[2]  
2-9
[3]  
BERENDSEN HH, 1988, CANCER RES, V48, P6891
[4]   The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies [J].
Bingle, L ;
Brown, NJ ;
Lewis, CE .
JOURNAL OF PATHOLOGY, 2002, 196 (03) :254-265
[5]   Strong induction of members of the chitinase family of proteins in atherosclerosis - Chitotriosidase and human cartilage gp-39 expressed in lesion macrophages [J].
Boot, RG ;
van Achterberg, TAE ;
van Aken, BE ;
Renkema, GH ;
Jacobs, MJHM ;
Aerts, JMFG ;
de Vries, CJM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :687-694
[6]  
CARNEY DN, 1985, CANCER RES, V45, P2913
[7]   Serum YKL-40 and colorectal cancer [J].
Cintin, C ;
Johansen, JS ;
Christensen, IJ ;
Price, PA ;
Sorensen, S ;
Nielsen, HJ .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1494-1499
[8]   YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes [J].
De Ceuninck, F ;
Gaufillier, S ;
Bonnaud, A ;
Sabatini, M ;
Lesur, C ;
Pastoureau, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 285 (04) :926-931
[9]   Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer [J].
Dehn, H ;
Hogdall, EVS ;
Johansen, JS ;
Jorgensen, M ;
Price, PA ;
Engelholm, SAA ;
Hogdall, CK .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2003, 82 (03) :287-293
[10]  
DELEIJ L, 1985, CANCER RES, V45, P6024